Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Psychopharmacology (Berl). 2012 Oct 25;226(1):53–63. doi: 10.1007/s00213-012-2883-x

Table 1.

Psychomotor and cognitive effects

Dose condition Circular lights Divided attention
Word recognition
Metamemory
Number completed Tracking deviation Proportion correct Hit rate False alarm rate d C Gamma correlation
Placebo 102.9 (2.1) 103.5 (2.8) 104.1 (3.0) 0.82 (0.02) 0.21 (0.03) 1.87 (0.15) −0.03 (0.07) 0.57 (0.05)
Ketamine
 0.2 mg/kg (i.m.) 94.7 (2.5) 101.6 (2.2) 97.2 (3.0) 0.78 (0.02) 0.22 (0.03) 1.66 (0.13) 0.02 (0.06) 0.60 (0.05)
 0.4 mg/kg (i.m.) 82.1 (3.0) 118.4 (4.4) 85.4 (4.5) 0.73 (0.04) 0.26 (0.03) 1.41 (0.13) 0.02 (0.11) 0.59 (0.06)
Triazolam
 0.2 mg/70 kg (p.o.) 87.8 (2.3)a 129.7 (5.6)a 92.1 (2.6) 0.74 (0.03) 0.25 (0.04) 1.53 (0.18) 0.04 (0.10) 0.51 (0.07)
 0.4 mg/70 kg (p.o.) 73.2 (2.5)a 172.1 (9.1) 79.2 (3.9) 0.62 (0.03)a 0.32 (0.04) 0.91 (0.14)a 0.13 (0.09) 0.41 (0.06)a

Values in bold indicate significant differences from placebo

a

Indicates a significant difference between the low or high doses of ketamine and triazolam, respectively